This is a call for submission of your findings and results from bedside to bench regarding SARS-CoV-2 (COVID-19) and cytometry. Time is critical here, and we all need additional information from the laboratories. As Editor-in-Chief of Cytometry Part A, dealing with single cell and particle research for basic research and medical applications, I am committed to making valuable information from our global group available quickly to everyone and to foster the research and development of diagnosis and therapy.
Cytometry Part A is establishing a "Fast Track" publication for submissions related to the Coronavirus. These will be published online in the next issue of the journal and will be freely available to the global community.
We are open to all kinds of findings, including improved lab procedures, single case or small cohort observations, lab experiment results, etc. The length of the manuscript should be limited to 2,000 words (13,000 characters including blanks), short 100-word abstracts, ten references, and two figures or tables. All the rest should be supplementary online material. Please check author guidelines for more info.